Statera Biopharma (STAB) Financials

$0.00

$0.00 (-33.33%)

As on 08-Sep-2026 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	1.49	--	41.55	47.07	7.59	--
Cost of Revenue	0.49	0.49	30.01	31.93	5.68	--
Gross Profit	-0.49	-0.49	11.54	15.15	1.91	--
Operating Expenses	28.83	30.74	10.50	2.81	5.94	7.55
Operating Profit (EBIT)	-98.34	-30.74	-10.50	-2.81	-4.80	-5.60
Other Income	--	--	2.93	1.37	0.84	--
Profit before Tax	-101.88	-101.88	-12.09	-3.22	-3.61	-9.71
Provision for Tax	72.53	--	1.13	0.12	0.29	-0.05
Profit after Tax (Net Income)	-174.41	-101.85	-13.22	-3.35	-3.61	-9.71
Minority Interest	--	0.02	--	0.21	--	--
Consolidated Profit	--	-101.85	-6.76	-5.72	-2.92	--

Liabilities ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	-1.57	-1.51	-3.66	-4.21	-1.45	2.20
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	11.43	11.43	0.07	4.21	0.01	0.01
Current Liabilities	11.25	11.25	4.62	1.52	0.91	2.21
Total Liabilities	21.17	21.17	1.04	0.00	4.53	9.63

Assets ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	17.01	17.01	0.11	0.03	0.06	0.05
Current Assets	4.16	4.16	0.93	0.00	4.48	9.58
Total Assets	21.17	21.17	1.04	0.00	4.53	9.63
Total Debt*	16.26	--	2.61	1.80	--	--
Net Current Assets	--	-7.09	-3.70	-4.21	--	--

Cashflow ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	-28.19	-28.19	-5.08	-0.24	-4.61	-6.61
Cash Flow from Investing Activities	13.46	13.46	-0.01	0.16	3.97	3.89
Cash from Financing Activities	20.99	20.99	5.68	0.23	0.06	--
Net Cash Inflow / Outflow	--	--	-2.12	2.81	-0.17	--

Financials Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-3.47	-2.87	-0.52	-0.20	-0.32	-0.86
Cash EPS ($)	-3.47	-2.86	-0.52	-0.20	-0.32	-0.86
Adjusted Book Value ($)	--	--	--	--	--	0.20
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.56	-0.79	-0.20	-0.01	-0.41	-0.59
Free Cash Flow per Share ($)	-0.56	-0.80	-0.20	-0.01	-0.41	-0.59

Profitability Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	-2,645.29	7,996.11	767.51	173.61	-966.05	-199.65
ROE (%)	11,344.34	3,945.79	336.26	118.28	-966.05	-199.65
ROA (%)	-823.86	-917.36	-2,550.21	-147.63	-51.00	-75.88
EBIT Margin (%)	-11,492.74	--	-26.39	-5.98	-63.23	--
Net Margin (%)	-11,728.58	--	-29.73	-6.91	-42.86	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	-1.00	-0.12	5.20	--	--
EBIT Growth (%)	-447.10	-184.94	-289.57	41.37	14.30	11.88
Net Profit Growth (%)	-71.24	-670.16	-294.97	7.30	62.79	-265.06
EPS Growth (%)	-0.21	-4.57	-1.59	0.38	0.63	-2.56
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	-0.02	-0.80	-6.69	-3.02	-3.16	-4.66
Price / Book Value	-2.56	-54.16	-24.21	-2.40	-7.86	20.56
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.11	-2.61	-8.23	-3.70	-1.52	-6.51
Close Price ($)	0.08	2.30	3.45	0.60	1.01	4.01
High Price ($)	2.38	10.97	5.43	2.16	4.15	5.55
Low Price ($)	0.08	1.99	0.52	0.50	1.01	1.35
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	-10.37	--	-0.72	-0.43	--	--
Short term debt to equity ratio	-3.08	--	-0.53	-0.43	-0.14	--
Current Ratio	0.37	0.37	0.20	0.00	4.91	4.33
Quick Ratio	0.21	--	0.20	0.28	4.83	--
Interest Coverage	-132.80	--	-9.70	-22.65	--	--

Operating Efficiency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	23.45	--	0.03	0.80	3.32	--
Asset Turnover	0.07	--	80.12	20.75	1.07	--
Receivable days	69.38	--	1.72	2.45	19.40	--
Inventory Days	1,351.86	-8.61	-2.65	-2.03	4.44	--
Payable days	2,965.72	2,488.09	31.00	14.56	10.95	--
Cash Conversion Cycle	-1,544.48	--	-31.94	-14.15	12.88	--